Advanced search
Publication Cover
Postgraduate Medicine Volume 124, 2012 - Issue 1
Submit an article Journal homepage
131
Views
14
CrossRef citations to date
0
Altmetric
Clinical Focus: Risk Reduction and Treatment of Metabolic and Vascular Disorders

Anticoagulation Prophylaxis in Orthopedic Surgery: An Efficiency Frontier Approach

Kristen Migliaccio–Walle Senior Decision Scientist, Institute for Clinical and Economic Review, Boston, MA; United BioSource Corporation, Lexington, MACorrespondence[email protected]
, BS,
Dale Rublee Director, Pfizer, Inc, New York, NY
, PhD &
Teresa A. Simon Director, Bristol-Myers Squibb, Princeton, NJ
, MPH
Pages 41-49 | Published online: 13 Mar 2015

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Nikhil Revankar, John Patterson, Ananth Kadambi, Vincent Raymond & Wissam El-Hadi BSc. (2013) A Canadian Study of the Cost-Effectiveness of Apixaban Compared With Enoxaparin for Post-Surgical Venous Thromboembolism Prevention. Postgraduate Medicine 125:4, pages 141-153.
Read now

Articles from other publishers (13)

Ioannis T. Farmakis, Stefano Barco, Anna C. Mavromanoli, Giancarlo Agnelli, Alexander T. Cohen, George Giannakoulas, Charles E. Mahan, Stavros V. Konstantinides & Luca Valerio. (2022) Cost‐of‐Illness Analysis of Long‐Term Health Care Resource Use and Disease Burden in Patients With Pulmonary Embolism: Insights From the PREFER in VTE Registry. Journal of the American Heart Association 11:20.
Crossref
. (2022) Recommendations from the ICM-VTE: General. Journal of Bone and Joint Surgery 104:Suppl 1, pages 4-162.
Crossref
Aziz Rezapour, Aghdas Souresrafil & Jalal Arabloo. (2021) Economic Evaluation of New Oral Anticoagulants in Prevention of Venous Thrombosis Following Joint Replacement Surgery: A Systematic Review. Clinical Therapeutics 43:5, pages e139-e156.
Crossref
Codie A. Primeau, Ishita Joshi, Bryn O. Zomar, Lyndsay E. Somerville, Holly T. Philpott, David D. McHugh, Brent A. Lanting, Edward M. Vasarhelyi & Jacquelyn D. Marsh. (2020) Cost-Effectiveness of Arthroplasty Management in Hip and Knee Osteoarthritis: a Quality Review of the Literature. Current Treatment Options in Rheumatology 6:3, pages 160-190.
Crossref
Dalia M. Dawoud, David Wonderling, Jessica Glen, Sedina Lewis, Xavier L. Griffin, Beverley J. Hunt, Gerard Stansby, Michael Reed, Nigel Rossiter, Jagjot Kaur Chahal, Carlos Sharpin & Peter Barry. (2018) Cost-Utility Analysis of Venous Thromboembolism Prophylaxis Strategies for People Undergoing Elective Total Hip and Total Knee Replacement Surgeries in the English National Health Service. Frontiers in Pharmacology 9.
Crossref
James Brockbank & Sorrel Wolowacz. (2017) Economic Evaluations of New Oral Anticoagulants for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement: A Systematic Review. PharmacoEconomics 35:5, pages 517-535.
Crossref
Jaime E. Ordóñez & Arlex U. Palacios. (2016) Análisis costo-efectividad de Apixaban versus Enoxaparina en pacientes sometidos a reemplazo total de cadera o rodilla en Colombia. Revista Colombiana de Ortopedia y Traumatología 30:4, pages 133-140.
Crossref
Tereza Lanitis, Robert Leipold, Melissa Hamilton, Dale Rublee, Peter Quon, Chantelle Browne & Alexander T. Cohen. (2016) Cost-effectiveness of Apixaban Versus Other Oral Anticoagulants for the Initial Treatment of Venous Thromboembolism and Prevention of Recurrence. Clinical Therapeutics 38:3, pages 478-493.e16.
Crossref
Stefano Barco, Alex L. Woersching, Alex C. Spyropoulos, Franco Piovella & Charles E. Mahan. (2017) European Union-28: An annualised cost-of-illness model for venous thromboembolism. Thrombosis and Haemostasis 115:04, pages 800-808.
Crossref
Carmen Suárez Fernández, Jorge F. Gómez Cerezo, Inmaculada Gómez Arrayás, Lourdes Betegón Nicolás, Marina de Salas-Cansado & Carlos Rubio-Terrés. (2013) Análisis de coste-efectividad de apixaban frente a enoxaparina en la prevención del tromboembolismo venoso en la artroplastia total de rodilla o cadera. PharmacoEconomics Spanish Research Articles 10:4, pages 107-118.
Crossref
J.F. Gómez-Cerezo, I. Gómez-Arrayás, C. Suárez-Fernández, L. Betegón-Nicolás, M. de Salas-Cansado & C. Rubio-Terrés. (2012) Cost-effectiveness analysis of apixaban compared to dabigatran in the prevention of venous thromboembolism in patients subjected to total knee or hip replacement. Revista Española de Cirugía Ortopédica y Traumatología (English Edition) 56:6, pages 459-470.
Crossref
J.F. Gómez-Cerezo, I. Gómez-Arrayás, C. Suárez-Fernández, L. Betegón-Nicolás, M. de Salas-Cansado & C. Rubio-Terrés. (2012) Análisis coste-efectividad de apixaban frente a dabigatrán en la prevención de la tromboembolia venosa en pacientes intervenidos de artroplastia total de rodilla o de cadera. Revista Española de Cirugía Ortopédica y Traumatología 56:6, pages 459-470.
Crossref
Emma D. Deeks. (2012) Apixaban. Drugs 72:9, pages 1271-1291.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.